We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+26%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.78B
AUM Growth
+$609M
Cap. Flow
+$311M
Cap. Flow %
17.44%
Top 10 Hldgs %
41.89%
Holding
349
New
60
Increased
99
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$20.1M
2
AMAT icon
Applied Materials
AMAT
+$17.2M
3
DE icon
Deere & Co
DE
+$17.1M
4
CB icon
Chubb
CB
+$16.9M
5
XYZ
Block Inc
XYZ
+$16M

Top Sells

Rank Stock Value
1
AXP icon
American Express
AXP
+$7.63M
2
NUE icon
Nucor
NUE
+$7M
3
AAPL icon
Apple
AAPL
+$4.71M
4
EXAS
Exact Sciences
EXAS
+$4.62M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$4.42M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Consumer Discretionary 15.17%
3 Industrials 12.94%
4 Healthcare 10.68%
5 Communication Services 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
101
Alibaba
BABA
$304B
$863K 0.05%
4,000
SCZ icon
102
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
$862K 0.05%
16,067
+10,406
+184% +$524K
RACE icon
103
Ferrari
RACE
$70.4B
$855K 0.05%
5,000
TDOC icon
104
Teladoc Health
TDOC
$1.21B
$855K 0.05%
4,480
+430
+11% +$75.4K
DHR icon
105
Danaher
DHR
$137B
$854K 0.05%
5,448
+1,917
+54% +$275K
BSX icon
106
Boston Scientific
BSX
$71.2B
$853K 0.05%
24,300
-4,700
-16% -$169K
CHKP icon
107
Check Point Software Technologies
CHKP
$12.7B
$829K 0.05%
7,715
UN
108
DELISTED
Unilever NV New York Registry Shares
UN
$804K 0.05%
15,100
XOM icon
109
ExxonMobil
XOM
$628B
$801K 0.04%
17,901
+4,000
+29% +$179K
SI
110
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$767K 0.04%
13,000
ADP icon
111
Automatic Data Processing
ADP
$106B
$748K 0.04%
5,025
+500
+11% +$71.6K
NKE icon
112
Nike
NKE
$62.3B
$745K 0.04%
7,595
+2,050
+37% +$189K
VRTX icon
113
Vertex Pharmaceuticals
VRTX
$124B
$712K 0.04%
2,451
+1,100
+81% +$298K
PHG icon
114
Philips
PHG
$25.9B
$707K 0.04%
18,619
-252
-1% -$8.77K
AZN icon
115
AstraZeneca
AZN
$244B
$705K 0.04%
6,663
-50
-0.7% -$5.16K
GSK icon
116
GSK
GSK
$103B
$698K 0.04%
13,680
+80
+0.6% +$4.1K
SHY icon
117
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$677K 0.04%
7,819
W icon
118
Wayfair
W
$14.9B
$658K 0.04%
+3,331
New +$498K
CP icon
119
Canadian Pacific Kansas City
CP
$79.2B
$638K 0.04%
12,500
J icon
120
Jacobs Solutions
J
$16.6B
$638K 0.04%
9,091
+1,209
+15% +$81.5K
SNY icon
121
Sanofi
SNY
$103B
$638K 0.04%
12,500
ITW icon
122
Illinois Tool Works
ITW
$83.3B
$631K 0.04%
3,606
MAS icon
123
Masco
MAS
$14.9B
$629K 0.04%
12,519
+4,500
+56% +$195K
ODFL icon
124
Old Dominion Freight Line
ODFL
$44.6B
$627K 0.04%
7,400
+2,900
+64% +$220K
BRK.B icon
125
Berkshire Hathaway Class B
BRK.B
$1.1T
$622K 0.03%
3,482
-10,000
-74% -$1.83M

Similar funds

R.H. Bluestein & Co's Q2 2020 Portfolio in Review

As of Q2 2020, R.H. Bluestein & Co held 349 positions worth $1.78B, up 52% from $1.18B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

R.H. Bluestein & Co deployed $311M of net new capital in Q2 2020, opening 60 new positions and adding to 99 existing holdings. Its largest new stake was Newmont: 339,383 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was American Express, an estimated $7.63M trimmed.

  • R.H. Bluestein & Co's largest Q2 2020 buy was Newmont: 339,383 shares worth $21M.
  • R.H. Bluestein & Co added most to Deere & Co in Q2 2020, an estimated $17.1M increase.
  • R.H. Bluestein & Co's biggest Q2 2020 reduction was American Express, cutting an estimated $7.63M.
  • R.H. Bluestein & Co fully exited Starbucks in Q2 2020, selling an estimated $4.01M.
  • R.H. Bluestein & Co's ten largest holdings make up 42% of its $1.78B portfolio in Q2 2020.
  • R.H. Bluestein & Co opened 60 new positions and closed 12 in Q2 2020.
  • R.H. Bluestein & Co's portfolio value rose 52% quarter-over-quarter to $1.78B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2020, filed 12 Aug 2020.